Patents Assigned to Ferndale Pharma Group, Inc.
  • Patent number: 11660263
    Abstract: The present invention is a composition and method of treatment for fragile skin, skin disorders, and skin conditions in general through topical systematic and periodic application of a formulation that generally may include ingredients such as but not limited to barrier repair ingredients such as but not limited to Skinmimics®, Retinol®, and glycolic acid; humectants such as but not limited to glycerin, propanediol, low and high molecular weight hyaluronic acids; redensifying agents such as but not limited to Timecode®, a lipo amino acid (palmitoyl glycine); and anti-inflammatory/anti-itch ingredients such as but not limited to soybean sterols, Timecode®, SymCalmin®, menthyl lactate, and niacinamide.
    Type: Grant
    Filed: December 2, 2021
    Date of Patent: May 30, 2023
    Assignee: Ferndale Pharma Group, Inc.
    Inventors: Stephen W. Clark, David A. Bass